Literature DB >> 21762780

7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase.

Ling Zou1, Li Li, Todd D Porter.   

Abstract

7-Dehydrocholesterol reductase (DHCR7) catalyzes the final step in cholesterol synthesis. The enzyme utilizes NADPH as a source of electrons and has been reported to require NADPH-cytochrome P450 reductase (POR) as its redox partner. To test this hypothesis, microsomes were prepared from the livers of mice in which hepatic cytochrome P450 reductase expression was extinguished during maturation. These microsomes contained negligible levels of POR but had 2.5-fold greater DHCR7 activity than did microsomes from wild-type mice. Consistent with this greater activity, immunoblot analysis of DHCR7 expression indicated that DHCR7 protein levels were elevated 2-fold in POR-null microsomes. Addition of POR to these microsomes provided no stimulation of DHCR7 activity, confirming the lack of a role for POR in DHCR7 activity. Because the original observation that POR was necessary for DHCR7 activity was based, in part, on antibody inhibition studies with POR antibody, the ability of an antibody to the full-length POR protein to inhibit DHCR7 activity and cytochrome c reductase activity was tested; the antibody had no effect on DHCR7 activity but decreased cytochrome c reductase activity (a POR-catalyzed reaction) by 50%. Immunoblot analysis further demonstrated no cross-reactivity between POR and DHCR7 with antibodies to either protein. We conclude that cytochrome P450 reductase is not involved in 7-dehydrocholesterol reductase activity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762780      PMCID: PMC3207014          DOI: 10.1016/j.jsbmb.2011.06.011

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  16 in total

1.  Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.

Authors:  H Nishino; T Ishibashi
Journal:  Arch Biochem Biophys       Date:  2000-02-15       Impact factor: 4.013

2.  Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.

Authors:  Colin J Henderson; Diana M E Otto; Dianne Carrie; Mark A Magnuson; Aileen W McLaren; Ian Rosewell; C Roland Wolf
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

3.  Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

Authors:  Xiu Jun Wang; Mark Chamberlain; Olga Vassieva; Colin J Henderson; C Roland Wolf
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

4.  Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase.

Authors:  Li Li; Todd D Porter
Journal:  Arch Biochem Biophys       Date:  2007-03-02       Impact factor: 4.013

5.  Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.

Authors:  Todd D Porter; Subhashis Banerjee; Elzbieta I Stolarczyk; Ling Zou
Journal:  Drug Metab Dispos       Date:  2011-03-02       Impact factor: 3.922

6.  Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase.

Authors:  Saloni Gill; Julian Stevenson; Ika Kristiana; Andrew J Brown
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

7.  Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol.

Authors:  Bao-Liang Song; Norman B Javitt; Russell A DeBose-Boyd
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 8.  Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.

Authors:  Forbes D Porter
Journal:  Eur J Hum Genet       Date:  2008-02-20       Impact factor: 4.246

9.  Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  Yvonne Lange; Daniel S Ory; Jin Ye; Michael H Lanier; Fong-Fu Hsu; Theodore L Steck
Journal:  J Biol Chem       Date:  2007-11-16       Impact factor: 5.157

10.  Chlorzoxazone hydroxylation in microsomes and hepatocytes from cytochrome P450 oxidoreductase-null mice.

Authors:  Li Li; Todd D Porter
Journal:  J Biochem Mol Toxicol       Date:  2009 Sep-Oct       Impact factor: 3.642

View more
  2 in total

Review 1.  From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D.

Authors:  John T Pinto; Arthur J L Cooper
Journal:  Adv Nutr       Date:  2014-03-01       Impact factor: 8.701

2.  Engineering Yarrowia lipolytica for Campesterol Overproduction.

Authors:  Hao-Xing Du; Wen-Hai Xiao; Ying Wang; Xiao Zhou; Yu Zhang; Duo Liu; Ying-Jin Yuan
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.